SGC
LLY icon

South Georgia Capital’s Eli Lilly LLY Stock Holding History

South Georgia Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-8,200
Closed -$483K – 215
2014
Q1 		$483K Hold
8,200
– – 0.41% 46
2013
Q4 		$418K Buy
+8,200
New +$411K 0.26% 54

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

South Georgia Capital's LLY Position: Q2 2014 in Review

South Georgia Capital sold out of Eli Lilly (LLY) in Q2 2014, closing a stake of 8,200 shares — an estimated $483K sold.

South Georgia Capital first reported a position in LLY in Q4 2013 and held it in 2 quarters. The position peaked at $483K in Q1 2014. 1,029 funds tracked by Wall St. Rank hold LLY as of Q2 2014.

  • South Georgia Capital reported no remaining Eli Lilly position as of Q2 2014 after selling out during the quarter.
  • South Georgia Capital sold 8,200 Eli Lilly shares in Q2 2014, an estimated $483K.
  • South Georgia Capital first reported a position in Eli Lilly in Q4 2013 and held it in 2 quarters.
  • South Georgia Capital's Eli Lilly position peaked at $483K in Q1 2014.
  • 1,029 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2014.

Based on South Georgia Capital's 13F filing for Q2 2014, filed 5 Aug 2014.